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n the September 2012 issue of Nature Genetics, 4 research groups reported NMNAT1 (OMIM 608700) mutations in patients with Leber congenital amaurosis (LCA). [1] [2] [3] [4] Most patients with these mutations had severe, early-onset vision loss accompanied by macular atrophy. Homozygous Nmnat1 knockout mice displayed early lethality, whereas heterozygous animals remained unaffected. 5 In our LCA cohort, we found compound heterozygous NMNAT1 variants in 6 probands. In previous studies, the most prevalent NMNAT1 variant was c.769G>A (p.Glu257Lys), observed in 38 of 106 alleles (35.8%). Collectively, this variant was found in 43 of 957 patients with LCA.
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Eleven of 4289 healthy European Americans are p.Glu257Lys heterozygotes (http://evs.gs.washington.edu /EVS/). When the Hardy-Weinberg principle is applied, homozygous alleles should be present in approximately 1 in 600 000 individuals. Because LCA occurs in 1 in 50 000 individuals, it can be inferred that this homozygous variant, if fully penetrant, should be responsible for approximately 8% of patients with LCA. Only 1 in 957 patients with LCA (0.1%), however, carried the p.Glu257Lys variant in a homozygous state.
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This 80-fold discrepancy between true and expected homozygosity rates in LCA led us to hypothesize that p.Glu257Lys is a hypomorphic variant that is not fully penetrant.
The activity of NMNAT1 was measured in erythrocytes in the 1 homozygous patient and was significantly lower than in his heterozygous mother.
3 This variant was also tested in a gene construct in HeLa cells and was suggested to be the most severe allele of 4 NMNAT1 variants.
In the Department of Human Genetics, Radboudumc, Nijmegen, exome database, the p.Glu257Lys variant was found in 10 of 850 persons. One of these individuals (patient II-4), who had intellectual disability, was carrying this substitution in a homozygous state ( Figure) . Interestingly, an unaffected sibling (individual II-1) was also homozygous for p.Glu257Lys. After clinical and ophthalmologic examination, individuals II-1 and II-4 did not have any ocular abnormalities.
On the basis of these findings, we assume that in persons of European descent there is a much larger group of healthy individuals who carry the p.Glu257Lys variant in a homozygous state than there are patients with LCA who carry this variant on both alleles. In patients with LCA carrying one p.Glu257Lys variant, the other NMNAT1 allele would then be predicted to be more severe. Additional evidence for this assumption was obtained using haplotype analysis. The patient with LCA who was previously homozygous for the p.Glu257Lys mutation was analyzed for single-nucleotide polymorphisms in NMNAT1 and proven to harbor this variant on 2 different haplotypes.
3 In our patients, one of these haplotypes was present in every person with the p.Glu257Lys variant, including the healthy individual (patient II-1) (data not shown). Consequently, we hypothesize that there may be differential expression of the 2 alleles harboring the p. The identification of this kind of transcriptional regulators is possible if the target gene of interest and its regulators are expressed highly enough in accessible patient cells. The identification of this kind of modifiers through high-throughput sequencing is challenging in view of the enormous genetic variability observed in the human population. Taken together, we propose that the NMNAT1 p.Glu257Lys variant is a hypomorphic variant that almost without exception causes LCA in combination with more severe NMNAT1 variants. Other variants in NMNAT1 are far less frequent and therefore have not been observed in a homozygous state. However, it may be speculated that they also represent combinations of mild and severe mutations or 2 alterations exerting a moderate effect, which cumulatively result in disease. In a homozygous state, the mild variants would generally not cause LCA, unless one or both gene copies show reduced transcription, possibly due to trans-or cis-acting modifier elements. This conclusion should be taken into consideration when families carrying this variant are genetically counseled, especially when the retinal phenotype lacks the macular atrophy and does not occur early in life. In those cases, the causal variants are most likely situated in other genes.
